Jeff Yass’s Aardvark Therapeutics AARD Stock Holding History
Bought
Maintained
Sold
Other funds holding AARD
Jeff Yass's AARD Position: Q3 2026 in Review
Jeff Yass increased its Aardvark Therapeutics (AARD) stake by 154% in Q3 2026, buying an estimated $225K and bringing the position to 60,976 shares worth $321K. The position accounts for ﹤0.01% of the portfolio, ranked #10808.
Jeff Yass first reported a position in AARD in Q2 2026 and has held it in 2 quarters since. 76 funds tracked by Wall St. Rank hold AARD as of Q3 2026.
- Jeff Yass held 60,976 shares of Aardvark Therapeutics worth $321K as of Q3 2026.
- Jeff Yass bought 36,951 Aardvark Therapeutics shares in Q3 2026, an estimated $225K.
- Aardvark Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #10808 holding.
- Jeff Yass first reported a position in Aardvark Therapeutics in Q2 2026 and has held it in 2 quarters since.
- 76 funds tracked by Wall St. Rank held Aardvark Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.